These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 25682686)

  • 1. [Sex differences of P-glycoprotein functional activity and expression in rabbits].
    Iakusheva EN; Chernykh IV; Shchul'kin AV; Kotliarova AA; Nikiforov AA
    Ross Fiziol Zh Im I M Sechenova; 2014 Aug; 100(8):944-52. PubMed ID: 25682686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of fexofenadine enantiomers in healthy subjects.
    Miura M; Uno T; Tateishi T; Suzuki T
    Chirality; 2007 Mar; 19(3):223-7. PubMed ID: 17230498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional absorption of fexofenadine in rat intestine.
    MacLean C; Moenning U; Reichel A; Fricker G
    Eur J Pharm Sci; 2010 Dec; 41(5):670-4. PubMed ID: 20869437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of piperine on the pharmacokinetics of fexofenadine, a P-glycoprotein substrate, in healthy volunteers.
    Bedada SK; Boga PK
    Eur J Clin Pharmacol; 2017 Mar; 73(3):343-349. PubMed ID: 27981349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans.
    Molimard M; Diquet B; Benedetti MS
    Fundam Clin Pharmacol; 2004 Aug; 18(4):399-411. PubMed ID: 15312146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of dose-dependent effects of itraconazole on the pharmacokinetic interaction with fexofenadine.
    Uno T; Shimizu M; Sugawara K; Tateishi T
    Drug Metab Dispos; 2006 Nov; 34(11):1875-9. PubMed ID: 16928786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of piperine, a major component of black pepper, on the intestinal absorption of fexofenadine and its implication on food-drug interaction.
    Jin MJ; Han HK
    J Food Sci; 2010 Apr; 75(3):H93-6. PubMed ID: 20492299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of St John's wort on the disposition of fexofenadine in the isolated perfused rat liver.
    Turkanovic J; Ngo SN; Milne RW
    J Pharm Pharmacol; 2009 Aug; 61(8):1037-42. PubMed ID: 19703347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some pharmacokinetic aspects of the lipophilic terfenadine and zwitterionic fexofenadine in humans.
    Chen C
    Drugs R D; 2007; 8(5):301-14. PubMed ID: 17767395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-dependent interaction between lopinavir/ritonavir and fexofenadine.
    van Heeswijk RP; Bourbeau M; Campbell P; Seguin I; Chauhan BM; Foster BC; Cameron DW
    J Clin Pharmacol; 2006 Jul; 46(7):758-67. PubMed ID: 16809801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative contribution of absorptive and secretory transporters to the intestinal absorption of fexofenadine in rats.
    Ujie K; Oda M; Kobayashi M; Saitoh H
    Int J Pharm; 2008 Sep; 361(1-2):7-11. PubMed ID: 18572335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term effect of quercetin on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein, in healthy volunteers.
    Kim KA; Park PW; Park JY
    Eur J Clin Pharmacol; 2009 Jun; 65(6):609-14. PubMed ID: 19221726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capsaicin pretreatment enhanced the bioavailability of fexofenadine in rats by P-glycoprotein modulation: in vitro, in situ and in vivo evaluation.
    Bedada SK; Appani R; Boga PK
    Drug Dev Ind Pharm; 2017 Jun; 43(6):932-938. PubMed ID: 28102715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of rifampin administration on the disposition of fexofenadine.
    Hamman MA; Bruce MA; Haehner-Daniels BD; Hall SD
    Clin Pharmacol Ther; 2001 Mar; 69(3):114-21. PubMed ID: 11240975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered oral bioavailability and pharmacokinetics of P-glycoprotein substrates by coadministration of biochanin A.
    Peng SX; Ritchie DM; Cousineau M; Danser E; Dewire R; Floden J
    J Pharm Sci; 2006 Sep; 95(9):1984-93. PubMed ID: 16850393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vectorial transport of fexofenadine across Caco-2 cells: involvement of apical uptake and basolateral efflux transporters.
    Ming X; Knight BM; Thakker DR
    Mol Pharm; 2011 Oct; 8(5):1677-86. PubMed ID: 21780830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fexofenadine in horses: pharmacokinetics, pharmacodynamics and effect of ivermectin pretreatment.
    Olsén L; Ingvast-Larsson C; Larsson P; Broström H; Bondesson U; Sundqvist M; Tjälve H
    J Vet Pharmacol Ther; 2006 Apr; 29(2):129-35. PubMed ID: 16515667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chiral Discrimination of P-glycoprotein in Parturient Women: Effect of Fluoxetine on Maternal-Fetal Fexofenadine Pharmacokinetics.
    Pinto L; Moreira FL; Nardotto GHB; Cavalli RC; Moisés ECD; Duarte G; Lanchote VL
    Pharm Res; 2020 Jun; 37(7):131. PubMed ID: 32557079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of St John's wort on the pharmacokinetics of fexofenadine.
    Wang Z; Hamman MA; Huang SM; Lesko LJ; Hall SD
    Clin Pharmacol Ther; 2002 Jun; 71(6):414-20. PubMed ID: 12087344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of single and multiple doses of itraconazole on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein.
    Shimizu M; Uno T; Sugawara K; Tateishi T
    Br J Clin Pharmacol; 2006 Sep; 62(3):372-6. PubMed ID: 16796706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.